1. Market Research
  2. > Healthcare
  3. > Health Services Market Trends
Age-related Vision Dysfunction - Epidemiology Forecast to 2030

Age-related Vision Dysfunction - Epidemiology Forecast to 2030

  • May 2021
  • 100 pages
  • ID: 6071730
  • Format: PDF
  • Delve Insight

Summary

Table of Contents

‘Age-related Vision Dysfunction - Epidemiology Forecast to 2030’ report delivers an in-depth understanding of the disease, historical and forecasted Age-related Vision Dysfunction epidemiology in the 7MM, i.e., the United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan.

Age-related Vision Dysfunction Understanding
The International Classification of Diseases 11 (2018) classifies vision impairment into two groups, distance and near presenting vision impairment. Beginning in the early to mid-forties, most adults may start to experience problems with their ability to see clearly at close distances, especially for reading and computer tasks. This normal change in the eye’s focusing ability will continue to progress over time. Vision loss among the elderly population is a major health care problem. Approximately one in three people have some form of vision-reducing eye disease by the age of 65. Beginning in the early to mid-forties, most adults may start to experience problems with their ability to see clearly at close distances, especially for reading and computer tasks. This normal change in the eye’s focusing ability will continue to progress over time. Adults over 40 may be particularly at risk for the development of eye and vision problems.
The process of aging contributes to visual loss through the deterioration of the function of the eye tissues and increased ocular pathology in the elderly. The process of pathology takes place over months to years, and patients usually have minimal symptoms initially. The five major causes of visual impairment in the elderly are presbyopia, age-related cataracts, age-related macular degeneration (AMD), glaucoma, and diabetic retinopathy, and the same set of indications we have taken forward for the epidemiology and market estimation.
Aging changes in various parts of the eye can result in several noticeable differences in how well a person can see. While not everyone will experience the same level of symptoms, the following are common age-related vision changes, some of the common symptoms include difficulty reading and doing close work, problems with glare, changes in color perception, reduced tear production, seeing distorted images, loss of side vision, seeing floaters and flashes, and fluctuating vision.
Age-related Vision Dysfunction Diagnosis
The comprehensive adult eye and vision examination provides the means to evaluate the function and health of the eyes and visual system and to obtain information to diagnose the cause of signs noted by the examiner or symptoms reported by the patient. It also provides the means to identify the presence of other ocular or systemic conditions that may exist without symptoms.
The diagnostic tests for the various vision diseases caused by old age include tests such as visual acuity tests, Fundus Fluorescein Angiography (FFA), Indocyanine green angiography (ICG), Amsler Grid Test, Visual Field Test, and Tonometry Test, among others.

Epidemiology Perspective
The Age-related Vision Dysfunction epidemiology division provides insights about historical and current Age-related Vision Dysfunction patient pool and forecasted trends for every seven major countries. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. This part of The report also provides the diagnosed patient pool and their trends along with assumptions undertaken.

Key Findings
In the year 2020, the total prevalent case of Age-related Vision Dysfunction was 374,306,439 cases in the 7MM which are expected to grow during the study period, i.e., 2018–2030.
The disease epidemiology covered in the report provides historical as well as forecasted Age-related Vision Dysfunction epidemiology [segmented as Total Prevalent Cases of Age-related Vision Dysfunction, Total Diagnosed Cases of Age-related Vision Dysfunction, Severity-specific Cases of Age-related Vision Dysfunction, and Treated cases of Age-related Vision Dysfunction] in the 7MM covering the United States, EU5 countries (Germany, France, Italy, Spain, and the United Kingdom), and Japan from 2018 to 2030.

Country Wise- Age-related Vision Dysfunction Epidemiology
Estimates show that the highest cases of Age-related Vision Dysfunction in the 7MM were in the United States, followed by Japan, Germany, Italy, France, the United Kingdom, and Spain in 2020.
• In the United States, the total number of prevalent cases of Age-related Vision Dysfunction was 159,952,427 cases in the year 2020 which are expected to grow during the study period, i.e., 2018–2030.
• In the year 2020, the total prevalent cases of Age-related Vision Dysfunction were 168,408,889 cases in EU-5 which are expected to grow during the study period, i.e., 2018–2030.
• In Japan, the total number of prevalent cases of Age-related Vision Dysfunction was 45,945,123 cases in the year 2020 which are expected to grow during the study period, i.e., 2018–2030.

Scope of the Report
• The Age-related Vision Dysfunction report covers a detailed overview explaining its causes, symptoms, classification, pathophysiology, diagnosis, and treatment patterns.
• The Age-related Vision Dysfunction Report and Model provide an overview of the risk factors and global trends of Age-related Vision Dysfunction in the seven major markets (7MM: The United States, Germany, France, Italy, Spain, and the United Kingdom, and Japan)
• The report provides insight about the historical and forecasted patient pool of Age-related Vision Dysfunction in seven major markets covering the United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan.
• The report helps to recognize the growth opportunities in the 7MM concerning the patient population.
• The report assesses the disease risk and burden and highlights the unmet needs of Age-related Vision Dysfunction.
• The report provides the segmentation of the Age-related Vision Dysfunction epidemiology by total prevalent cases in the 7MM.
• The report provides the segmentation of the Age-related Vision Dysfunction epidemiology by total diagnosed cases in the 7MM.
• The report provides the segmentation of the Age-related Vision Dysfunction epidemiology by severity-specific cases in the 7MM.
• The report provides the segmentation of the Age-related Vision Dysfunction epidemiology by treated cases in the 7MM.

Report Highlights

• 10-Year Forecast of Age-related Vision Dysfunction epidemiology
• 7MM Coverage
• Total Prevalent Cases of Age-related Vision Dysfunction
• Total Diagnosed Cases of Age-related Vision Dysfunction
• Severity-specific Cases of Age-related Vision Dysfunction
• Treated Cases of Age-related Vision Dysfunction
KOL-Views
We interview KOL’s and SME’s opinions through primary research to fill the data gaps and validate our secondary research. The opinion helps to understand the total patient population and current treatment pattern. This will support the clients in potential upcoming novel treatment by identifying the overall scenario of the indications.

Key Questions Answered
• What will be the growth opportunities in the 7MM concerning the patient population of Age-related Vision Dysfunction?
• What are the key findings of the Age-related Vision Dysfunction epidemiology across the 7MM and which country will have the highest number of patients during the study period (2018–2030)?
• What would be the total number of patients with Age-related Vision Dysfunction across the 7MM during the study period (2018–2030)?
• Among the EU5 countries, which country will have the highest number of patients during the study period (2018–2030)?
• At what CAGR the patient population is expected to grow in the 7MM during the study period (2018–2030)?
• What are the various recent and upcoming events which are expected to improve the diagnosis of Age-related Vision Dysfunction?

Reasons to buy
The Age-related Vision Dysfunction Epidemiology report will allow the user to -
• Develop business strategies by understanding the trends shaping and driving the global Age-related Vision Dysfunction market
• Quantify patient populations in the global Age-related Vision Dysfunction market to improve product design, pricing, and launch plans
• Organize sales and marketing efforts by identifying the gender that presents the best opportunities for Age-related Vision Dysfunction therapeutics in each of the markets covered
• Understand the magnitude of Age-related Vision Dysfunction population by its severity
• The Age-related Vision Dysfunction epidemiology report and model were written and developed by Masters and Ph.D. level epidemiologists
• The Age-related Vision Dysfunction Epidemiology Model developed is easy to navigate, interactive with dashboards, and epidemiology based on transparent and consistent methodologies. Moreover, the model supports data presented in the report and showcases disease trends over a 10-year forecast period using reputable sources

Key Assessments
• Patient Segmentation
• Disease Risk and Burden
• Risk of disease by the segmentation
• Factors driving growth in a specific patient population

Geographies Covered
• The United States
• EU5 (Germany, France, Italy, Spain, and the United Kingdom)
• Japan
Study Period: 2018–2030
• In the year 2020, the total prevalent case of Age-related Vision Dysfunction was 374,306,439 cases in the 7MM, and the US, in 2020, accounted for 159,952,427 cases (the highest number), which will probably rise during the study period, i.e., 2018–2030.
• In the 7MM, the total diagnosed cases of Age-related Vision Dysfunction were 134,709,728 in the US, 140,935,350 in the EU5, and 38,601,941 cases in Japan in the year 2020.
• In the 7MM, the total severity-specific prevalent cases of Age-related Vision Dysfunction were 244,080,761 for moderate to severe cases in the year 2020.

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 150+ Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
  • Single User License — provides access to the report by one individual.
  • Department License — allows you to share the report with up to 5 users
  • Site License — allows the report to be shared amongst all employees in a defined country
  • Corporate License — allows for complete access, globally.

ReportLinker may already be registered as a supplier with your company. If you want to Order by PO, check with us first and we'll let you know if we are a registered supplier and what the vendor number is. Otherwise, we'll provide you with the necessary information to register ReportLinker as a vendor.

Ahmad helps you find the right report:
Testimonials

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

We were impressed with the support that ReportLinker’s research specialists’ team provided. The report we purchased was useful and provided exactly what we want.

Category Manager at
Ikea

ReportLinker gave access to reliable and useful data while avoiding dispersing resources and spending too much time on unnecessary research.

Executive Director at
PwC Advisory

The customer service was fast, responsive, and 100% professional in all my dealings (...) If we have more research needs, I'll certainly prioritize working with ReportLinker!

Scott Griffith

Vice President Marketing at
Maurice Sporting Goods

The research specialist provided prompt, helpful instructions for accessing ReportLinker's product. He also followed up to make sure everything went smoothly and to ensure an easy transition to the next stage of my research

Jessica P Huffman

Research Associate at
American Transportation Research Institute

Excellent customer service. Very responsive and fast.

Director, Corporate Strategy at
Ingredion

I reached out to ReportLinker for a detailed market study on the Air Treatment industry. The quality of the report, the research specialist’s willingness to solve my queries exceeded my expectations. I would definitely recommend ReportLinker for in-depth industry information.

Mariana Mendoza

Global Platform Senior Manager at
Whirlpool Corporation

Thanks! I like what you've provided and will certainly come back if I need to do further research works.

Bee Hin Png

CEO at
LDR Pte Ltd

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

FAQ
  • How we can help
    • I am not sure if the report I am interested in will fulfill my needs. Can you help me?
    • Yes, of course. You can call us at +33(0) 4 37 65 17 03 or drop us an email at researchadvisor@reportlinker.com to let us know more about your requirements.
    • We buy reports often - can ReportLinker get me any benefits?
    • Yes. Set up a call with a Senior Research Advisor to learn more - researchadvisor@reportlinker.com or +33(0) 4 37 65 17 03.
    • I have had negative experiences with market research reports before. How can you avoid this from happening again?
    • We advise all clients to read the TOC and Summary and list your questions so that we can get more insight for you before you make any purchase decision. A research advisor will accompany you so that you can compare samples and reports from different sources, and choose the study that is right for you.

  • Report Delivery
    • How and when I will receive my Report?
    • Most reports are delivered right away in a pdf format, while others are accessed via a secure link and access codes. Do note that sometimes reports are sent within a 12 hour period, depending on the time zones. However, you can contact us to escalate this. Should you need a hard copy, you can check if this option is offered for the particular report, and pay the related fees.
  • Payment conditions
    • What payment methods do you accept?
      1. Credit card : VISA, American Express, Mastercard, or
      2. You can download an invoice to pay by wire transfer, check, or via a Purchase Order from your company, or
      3. You can pay via a Check made out in US Dollars, Euros, or British Pounds for the full amount made payable to ReportLinker
    • What are ReportLinker’s Payment Terms?
    • All payments must normally be submitted within 30 days. However, you can let us know if you need extended time.
    • Are Taxes and duties included?
    • All companies based in France must pay a 20% tax per report. The same applies to all individuals based in the EU. All EU companies must supply their VAT number when purchasing to avoid this charge.
    • I’m not satisfied. Can I be refunded?
    • No. Once your order has been processed and the publisher has received a notification to send you the report, we cannot issue any refund or cancel any order. As these are not ‘traditional’ products that can be returned, reports that are dispatched are considered to be ‘consumed’.
  • User license
    • The license that you should acquire depends on the number of persons that need to access the report. This can range from Single User (only one person will have the right to read or access the report), or Department License (up to 5 persons), to Site License (a group of persons based in the same company location), or Corporate License (the entire company personnel based worldwide). However, as publishers have different terms and conditions, we can look into this for you.
Purchase Reports From Reputable Market Research Publishers

Diabetic Macular Edema (DME)- Market Insight, Epidemiology and Market Forecast -2030

  • $ 6950
  • May 2021
  • 250 pages

‘Diabetic macular edema (DME)- Market Insights, Epidemiology, and Market Forecast—2030’ report delivers an in-depth understanding of the DME , historical and forecasted epidemiology as well as the ...

  • United States
  • Japan
  • Hospital
  • Compression Therapy
  • Industry analysis
  • Elderly Population

ref:plp2021

Reportlinker.com © Copyright 2021. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on